Skip to main content
Premium Trial:

Request an Annual Quote

GenoSpectra Closes $20M Series B Financing Round

NEW YORK, Dec. 20 - Start-up genomic tool company GenoSpectra has closed on $20 million in a Series B round of private equity financing, the company said on Wednesday.

 

The round was led by Frazier Healthcare Ventures, and the BioMedical Sciences Investment Fund of the Singapore Economic Development Board, HBM BioVentures, and Novartis BioVentures tagged along.

 

The Fremont, Calif.-based firm develops DNA and protein microarrays as well as tools for high throughput drug screening.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.